Arbutus Biopharma Corporation (ABUS) Ownership

$3.27

south_east
-$0.15 (-4.39%)
Day's range
$3.27
Day's range
$3.42

Arbutus Biopharma Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WHITEFORT CAPITAL MANAGEMENT, LP 02/14/2025 13.24 M $43.30 M   2.91% 7.01%
BLACKROCK FUNDING, INC. /DE 02/07/2025 12.94 M $42.31 M   5.88% 6.85%
VANGUARD GROUP INC 02/11/2025 8.98 M $29.37 M   0.70% 4.75%
TWO SEAS CAPITAL LP 02/18/2025 8.74 M $28.58 M   4.22% 4.62%
STATE STREET CORP 02/14/2025 5.03 M $16.44 M   14.06% 2.66%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 3.48 M $11.39 M   0.97% 1.84%
BLACKBARN CAPITAL PARTNERS LP 02/14/2025 2.34 M $7.66 M   13.08% 1.24%
RUBRIC CAPITAL MANAGEMENT LP 02/14/2025 1.68 M $5.50 M   0.00% 0.89%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 1.65 M $5.40 M   -43.09% 0.87%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 1.55 M $5.08 M   -25.58% 0.82%
02/12/2025 1.46 M $4.77 M   100.00% 0.77%
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 1.36 M $5.24 M   -0.72% 0.72%
FOURWORLD CAPITAL MANAGEMENT LLC 02/14/2025 1.23 M $4.01 M   -58.73% 0.65%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.22 M $4.00 M   0.82% 0.65%
HUDSON BAY CAPITAL MANAGEMENT LP 02/14/2025 1.11 M $3.64 M   8.01% 0.59%
WOODLINE PARTNERS LP 02/14/2025 971,628 $3.18 M   45.42% 0.51%
JPMORGAN CHASE & CO 02/12/2025 896,258 $2.93 M   900.44% 0.47%
SABA CAPITAL MANAGEMENT, L.P. 02/14/2025 887,993 $2.90 M   31.28% 0.47%
CORBIN CAPITAL PARTNERS, L.P. 02/11/2025 682,487 $2.23 M   -20.02% 0.36%
GOLDMAN SACHS GROUP INC 02/11/2025 531,878 $1.74 M   -5.09% 0.28%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 513,302 $1.68 M   3.32% 0.27%
BANK OF MONTREAL /CAN/ 02/13/2025 455,880 $1.49 M   3.54% 0.24%
FREESTONE CAPITAL HOLDINGS, LLC 02/06/2025 442,500 $1.45 M   -0.16% 0.23%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2025 420,709 $1.38 M   0.19% 0.22%
QUINN OPPORTUNITY PARTNERS LLC 02/13/2025 404,879 $1.32 M   72.19% 0.21%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 390,337 $1.28 M   129.22% 0.21%
BANK OF NEW YORK MELLON CORP 02/04/2025 353,374 $1.16 M   0.23% 0.19%
MILLENNIUM MANAGEMENT LLC 02/14/2025 343,028 $1.12 M   36.69% 0.18%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 313,307 $1.02 M   0.00% 0.17%
BARCLAYS PLC 02/13/2025 298,253 $975,000   9.64% 0.16%
SWISS NATIONAL BANK 02/10/2025 276,300 $903,501   0.00% 0.15%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 247,996 $810,947   -19.05% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 244,600 $799,842   -34.21% 0.13%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 02/14/2025 202,541 $662,309   100.00% 0.11%
RHUMBLINE ADVISERS 01/30/2025 188,598 $616,706   6.03% 0.10%
CITIGROUP INC 02/12/2025 187,720 $613,844   72.14% 0.10%
SQUAREPOINT OPS LLC 02/14/2025 184,500 $603,315   100.00% 0.10%
SQUAREPOINT OPS LLC 02/14/2025 178,099 $582,384   174.81% 0.09%
CAPTION MANAGEMENT, LLC 02/14/2025 175,000 $572,250   100.00% 0.09%
DEUTSCHE BANK AG\ 02/14/2025 171,766 $561,675   77.90% 0.09%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 162,277 $530,646   -73.50% 0.09%
LMR PARTNERS LLP 02/14/2025 158,249 $517,474   -19.68% 0.08%
CITIGROUP INC 02/12/2025 150,000 $490,500   -52.74% 0.08%
RAFFERTY ASSET MANAGEMENT, LLC 02/14/2025 146,803 $480,046   27.63% 0.08%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 02/14/2025 132,758 $434,119   -1.13% 0.07%
ALLIANCEBERNSTEIN L.P. 02/12/2025 120,240 $393,185   -12.63% 0.06%
LEGAL & GENERAL GROUP PLC 02/13/2025 118,693 $388,125   -18.59% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 115,222 $376,776   9.80% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 112,000 $366,240   -19.42% 0.06%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 02/13/2025 106,615 $348,631   69.23% 0.06%

Arbutus Biopharma Corporation institutional Ownership - FAQ's

During the previous two years, 182 institutional investors and hedge funds held shares of Arbutus Biopharma Corporation. The most heavily invested institutionals were:

Whitefort Capital Management, LP: 13.24 M

BlackRock Funding, Inc. /DE: 12.94 M

VANGUARD GROUP INC: 8.98 M

Two Seas Capital LP: 8.74 M

STATE STREET CORP: 5.03 M

GEODE CAPITAL MANAGEMENT, LLC: 3.48 M

54.90% of Arbutus Biopharma Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 115.40 M shares in the last 24 months. This purchase volume represents approximately $377.36 M in transactions.